Reuters logo
BRIEF-Achaogen submits Plazomicin new drug application to FDA
October 26, 2017 / 12:31 PM / 22 days ago

BRIEF-Achaogen submits Plazomicin new drug application to FDA

Oct 26 (Reuters) - Achaogen Inc

* Achaogen submits Plazomicin new drug application (NDA) to the U.S. FDA for treatment of complicated urinary tract infections and bloodstream infections

* Achaogen Inc - co also intends to submit an application for registration of Plazomicin​ in European Union in 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below